The study evaluates a web-based digital toolkit designed to screen for intimate partner violence (IPV), post-traumatic stress disorder (PTSD), and related mental health concerns within opioid treatment programs. Providers use the toolkit during routine care with patients receiving treatment for opioid use disorder. The study examines how the toolkit is implemented into clinic workflows and whether its use improves detection, referral, and patient outcomes.

Inclusion criteria for all participants:

• Age 18 and older
• Able to understand and sign a consent form in English

Inclusion criteria for OTPs:

• Current experience working in one of the three opioid treatment clinics serving as a recruitment site for this study
• Health care professional training (e.g., social worker, counselor, physician, psychologist, nurse practitioner)

Exclusion criteria for OTPs:

- None

Inclusion criteria for patients with OUD:

• Report opioids as their primary substance of use for which they are seeking treatment
• Receive treatment at one of the three opioid treatment clinics serving as a recruitment site for this study

Exclusion criteria for patients with OUD:

• An acute medical problem requiring inpatient treatment (e.g., detoxification)
• Incarceration at the time of the study

Demographic, survey, and clinical data will be acquired. The raw interview, survey, and clinical data will be stored within a secure computing environment. All direct identifiers will be removed and maintained in a secure file. All other scientific data (coded interview data, scale composites, recodes) will be both preserved and shared via ICPSR. Documentation to be made available will include a study protocol, reference to study publication of primary outcomes, data sets, case report forms, a data dictionary, and study-specific notes. Variables in the data dictionary will include a description, variable name, variable label, and standard codes for missing values.

The first batch of data will be deposited 6 months after enrollment of the first participants and data will be deposited every 6 months thereafter until study completion. The research community will have access to the full data set approximately 18 months following the end of the randomized clinical trial or after the primary paper has been accepted for publication, whichever happens first.

Data will be findable for the research community through ICPSR. For all publications, an ICPSR study will be created and assigned a digital object identifier (DOI). The DOI will be referenced in the publication to allow the research community to access the data used.